Neuland Laboratories Limited (NSE: NEULANDLAB)
India
· Delayed Price · Currency is INR
15,115
+226 (1.51%)
Nov 21, 2024, 12:59 PM IST
Neuland Laboratories Revenue
Neuland Laboratories had revenue of 3.11B INR in the quarter ending September 30, 2024, a decrease of -25.59%. This brings the company's revenue in the last twelve months to 15.28B, up 4.87% year-over-year. In the fiscal year ending March 31, 2024, Neuland Laboratories had annual revenue of 15.59B with 30.81% growth.
Revenue (ttm)
15.28B
Revenue Growth
+4.87%
P/S Ratio
n/a
Revenue / Employee
9.30M
Employees
1,643
Market Cap
189.80B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 15.59B | 3.67B | 30.81% |
Mar 31, 2023 | 11.91B | 2.40B | 25.20% |
Mar 31, 2022 | 9.52B | 147.07M | 1.57% |
Mar 31, 2021 | 9.37B | 1.73B | 22.64% |
Mar 31, 2020 | 7.64B | 965.74M | 14.47% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionNeuland Laboratories News
- 9 days ago - Neuland Laboratories shares surge nearly 10% amid AbbVie’s phase 2 setback on schizophrenia drug - Business Upturn
- 14 days ago - Goldman Sachs maintains buy on Neuland Labs, raises target to Rs 15,250; sees 7% upside potential - Business Upturn
- 15 days ago - Neuland Laboratories shares plunge over 13% after disappointing Q2 FY25 results; revenue down 25.1% YoY to ₹315.2 crore, PAT declines 64.1% - Business Upturn
- 15 days ago - Neuland Laboratories Q2 FY25 Results: Revenue down 25.1% YoY to ₹315.2 crore, PAT declines 64.1% - Business Upturn
- 25 days ago - Stocks to Buy This Diwali: AngelOne sees Neuland Laboratories reaching ₹19,580, with 25% growth potential - Business Upturn
- 5 weeks ago - B&K on Neuland Labs: Maintains Buy call, raises target price to Rs 20,000, sees 40% upside - Business Upturn
- 7 weeks ago - Goldman Sachs initiates ‘buy’ call on Neuland Labs, check target price - Business Upturn
- 2 months ago - Q1 2025 Neuland Laboratories Ltd Earnings Call Transcript - GuruFocus